Article
Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening
27 Jun 2023
Abstract excerpt
includes human SARS-CoV, SARS-CoV-2, and hundreds of genetically related bat viruses. The continuous evolution of SARS-CoV-2 has led to the striking evasion of neutralizing antibody (NAb) drugs and convalescent plasma. Antibodies with broad activity across sarbecoviruses would be helpful to combat current SARS-CoV-2 mutations and longer term animal virus spillovers. The study of pan-sarbecovirus NAbs described...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
